SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 33 filers reported holding SPRING BK PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $952,000 | -6.8% | 276,656 | 0.0% | 0.16% | +34.4% |
| Q2 2019 | $1,021,000 | -64.8% | 276,656 | 0.0% | 0.12% | -65.0% |
| Q1 2019 | $2,902,000 | +11.0% | 276,656 | +9.9% | 0.35% | -1.7% |
| Q4 2018 | $2,615,000 | -25.6% | 251,656 | -13.7% | 0.36% | -4.8% |
| Q3 2018 | $3,514,000 | +125.3% | 291,656 | +121.5% | 0.37% | +114.4% |
| Q2 2018 | $1,560,000 | -23.0% | 131,656 | 0.0% | 0.17% | -21.6% |
| Q1 2018 | $2,025,000 | +22.1% | 131,656 | +6.7% | 0.22% | +7.2% |
| Q4 2017 | $1,658,000 | -20.2% | 123,383 | 0.0% | 0.21% | -22.8% |
| Q3 2017 | $2,078,000 | +36.4% | 123,383 | +9.7% | 0.27% | +60.5% |
| Q2 2017 | $1,523,000 | – | 112,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 785,950 | $9,314,000 | 0.91% |
| Morse Asset Management, Inc | 177,500 | $2,103,000 | 0.58% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 281,213 | $3,332,000 | 0.38% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $860,000 | 0.33% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,883,000 | 0.31% |
| Private Capital Advisors, Inc. | 52,335 | $620,000 | 0.19% |
| SECTORAL ASSET MANAGEMENT INC | 131,656 | $1,560,000 | 0.17% |
| Lee Financial Co | 18,750 | $222,000 | 0.05% |
| Baker Brothers Advisors | 373,144 | $4,422,000 | 0.03% |
| Alyeska Investment Group, L.P. | 200,000 | $2,370,000 | 0.02% |